Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
The Journal of Urology
|
February 29, 2024
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
Todd M Morgan, Stephen A Boorjian, Mark K Buyyounouski, et al.
European Urology Oncology
|
June 16, 2019
Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3Tesla Multiparametric Prostate Magnetic Resonance Imaging
Matthew Truong, Janet E Baack Kukreja, Soroush Rais-Bahrami, et al.
BJU International
|
June 11, 2015
Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance
John W Davis, John F Ward, Curtis A Pettaway, et al.
BJU International
|
June 5, 2024
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates
Andrew W Hahn, Ganiraju C Manyam, Brian F Chapin, et al.
BJU International
|
September 24, 2017
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort
Pierre Blanchard, John W Davis, Steven J Frank, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2023
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)
Bilal A Siddiqui, Brian F Chapin, Sonali Jindal, et al.
Biomarker Research
|
November 10, 2024
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance
Justin R Gregg, Lisa Newcomb, Ranran Wu, et al.
Cancer
|
November 20, 2019
Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends
Chad Tang, Karen E Hoffman, Pamela K Allen, et al.
Clinical and Translational Radiation Oncology
|
August 27, 2024
Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center
Alan J Sosa, Michael K Rooney, Howard D Thames, et al.
European Urology
|
August 1, 2025
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial
Alexander D Sherry, Bilal A Siddiqui, Cara Haymaker, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
The Journal of Urology
|
February 29, 2024
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
Todd M Morgan, Stephen A Boorjian, Mark K Buyyounouski, et al.
European Urology Oncology
|
June 16, 2019
Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3Tesla Multiparametric Prostate Magnetic Resonance Imaging
Matthew Truong, Janet E Baack Kukreja, Soroush Rais-Bahrami, et al.
BJU International
|
June 11, 2015
Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance
John W Davis, John F Ward, Curtis A Pettaway, et al.
BJU International
|
June 5, 2024
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates
Andrew W Hahn, Ganiraju C Manyam, Brian F Chapin, et al.
BJU International
|
September 24, 2017
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort
Pierre Blanchard, John W Davis, Steven J Frank, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2023
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)
Bilal A Siddiqui, Brian F Chapin, Sonali Jindal, et al.
Biomarker Research
|
November 10, 2024
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance
Justin R Gregg, Lisa Newcomb, Ranran Wu, et al.
Cancer
|
November 20, 2019
Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends
Chad Tang, Karen E Hoffman, Pamela K Allen, et al.
Clinical and Translational Radiation Oncology
|
August 27, 2024
Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center
Alan J Sosa, Michael K Rooney, Howard D Thames, et al.
European Urology
|
August 1, 2025
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial
Alexander D Sherry, Bilal A Siddiqui, Cara Haymaker, et al.
Page
of 12